COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

10.1016/j.phrs.2022.106201

Saved in:

Bibliographic Details
Main Authors:	Ho, Wei Shen, Zhang, Ruirui, Tan, Yeong Lan, Chai, Christina Li Lin
Other Authors:	PHARMACY
Format:	Review
Language:	English
Published:	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Antivirals COVID-19 Small molecule therapeutics Drug discovery Chloroquine (PubChem CID 2719) Ivermectin (PubChem CID 6321424) Lopinavir (PubChem CID 92727) Ritonavir (PubChem CID 392622) Remdesivir (PubChem CID 121304016) Dexamethasone (PubChem CID 5743) Baricitinib (PubChem CID 44205240) Molnupiravir (Pubchem CID 145996610) Nirmatrelvir (PubChem CID 155903259) Chemical compounds studied in this article Hydroxychloroquine (PubChem CID 3652) ACUTE RESPIRATORY SYNDROME IN-VITRO LOPINAVIR-RITONAVIR EBOLA-VIRUS IVERMECTIN INHIBITORS CHLOROQUINE EFFICACY REMDESIVIR DRUG
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/226977
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-226977
record_format	dspace
spelling	sg-nus-scholar.10635-2269772024-04-05T08:58:58Z COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt? Ho, Wei Shen Zhang, Ruirui Tan, Yeong Lan Chai, Christina Li Lin PHARMACY Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Antivirals COVID-19 Small molecule therapeutics Drug discovery Chloroquine (PubChem CID 2719) Ivermectin (PubChem CID 6321424) Lopinavir (PubChem CID 92727) Ritonavir (PubChem CID 392622) Remdesivir (PubChem CID 121304016) Dexamethasone (PubChem CID 5743) Baricitinib (PubChem CID 44205240) Molnupiravir (Pubchem CID 145996610) Nirmatrelvir (PubChem CID 155903259) Chemical compounds studied in this article Hydroxychloroquine (PubChem CID 3652) ACUTE RESPIRATORY SYNDROME IN-VITRO LOPINAVIR-RITONAVIR EBOLA-VIRUS IVERMECTIN INHIBITORS CHLOROQUINE EFFICACY REMDESIVIR DRUG 10.1016/j.phrs.2022.106201 PHARMACOLOGICAL RESEARCH 179 2022-06-13T03:39:05Z 2022-06-13T03:39:05Z 2022-05-01 2022-06-12T01:44:46Z Review Ho, Wei Shen, Zhang, Ruirui, Tan, Yeong Lan, Chai, Christina Li Lin (2022-05-01). COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?. PHARMACOLOGICAL RESEARCH 179. ScholarBank@NUS Repository. https://doi.org/10.1016/j.phrs.2022.106201 10436618 10961186 https://scholarbank.nus.edu.sg/handle/10635/226977 en ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Antivirals COVID-19 Small molecule therapeutics Drug discovery Chloroquine (PubChem CID 2719) Ivermectin (PubChem CID 6321424) Lopinavir (PubChem CID 92727) Ritonavir (PubChem CID 392622) Remdesivir (PubChem CID 121304016) Dexamethasone (PubChem CID 5743) Baricitinib (PubChem CID 44205240) Molnupiravir (Pubchem CID 145996610) Nirmatrelvir (PubChem CID 155903259) Chemical compounds studied in this article Hydroxychloroquine (PubChem CID 3652) ACUTE RESPIRATORY SYNDROME IN-VITRO LOPINAVIR-RITONAVIR EBOLA-VIRUS IVERMECTIN INHIBITORS CHLOROQUINE EFFICACY REMDESIVIR DRUG
spellingShingle	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Antivirals COVID-19 Small molecule therapeutics Drug discovery Chloroquine (PubChem CID 2719) Ivermectin (PubChem CID 6321424) Lopinavir (PubChem CID 92727) Ritonavir (PubChem CID 392622) Remdesivir (PubChem CID 121304016) Dexamethasone (PubChem CID 5743) Baricitinib (PubChem CID 44205240) Molnupiravir (Pubchem CID 145996610) Nirmatrelvir (PubChem CID 155903259) Chemical compounds studied in this article Hydroxychloroquine (PubChem CID 3652) ACUTE RESPIRATORY SYNDROME IN-VITRO LOPINAVIR-RITONAVIR EBOLA-VIRUS IVERMECTIN INHIBITORS CHLOROQUINE EFFICACY REMDESIVIR DRUG Ho, Wei Shen Zhang, Ruirui Tan, Yeong Lan Chai, Christina Li Lin COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
description	10.1016/j.phrs.2022.106201
author2	PHARMACY
author_facet	PHARMACY Ho, Wei Shen Zhang, Ruirui Tan, Yeong Lan Chai, Christina Li Lin
format	Review
author	Ho, Wei Shen Zhang, Ruirui Tan, Yeong Lan Chai, Christina Li Lin
author_sort	Ho, Wei Shen
title	COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
title_short	COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
title_full	COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
title_fullStr	COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
title_full_unstemmed	COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
title_sort	covid-19 and the promise of small molecule therapeutics: are there lessons to be learnt?
publisher	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/226977
_version_	1800915426020950016

COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

Similar Items